Mini Oral Abstract Sessions—Tuesday, September 25, 2018
MA15.02 Long-Term Safety and Clinical Activity Results from a Phase Ib Study of Erlotinib Plus Atezolizumab in Advanced NSCLC

https://doi.org/10.1016/j.jtho.2018.08.440Get rights and content
Under an Elsevier user license
open archive

Cited by (0)